Novo Nordisk sues Hims & Hers over copycat weight-loss drugs
The litigation targets sales of imitation versions of the drugmaker's semaglutide products by the telehealth company.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 11 13:13 ETSource: Olhar Digital
The wire
- 01Novo Nordisk has filed suit against telehealth firm Hims & Hers over what it describes as copycat weight-loss drugs, according to Olhar Digital.
- 02Telehealth operators selling compounded or imitation semaglutide face mounting litigation risk now that the branded shortage-era window has closed.
- 03Court filing details, claims and the venue were not described in the report, and Hims & Hers' response is not yet known.
From the source
Read at olhardigital.com.brnovo nordisk sues hims & hers over copycat weight-loss drugs
